Table II.
Group | No. | IGF-1 level (ng/ml) |
---|---|---|
0 | 18 | 200.33±126.51 |
P | 2 | 308.75±55.96 |
A | 13 | 264.03±118.97 |
G | 6 | 109.09±50.57 |
Group 0, control group; group P, patients with papillary carcinoma; group A, patients with thyroid adenoma; group G, patients with thyroid goiter; IGF-1, insulin-like growth factor-1.